Last reviewed · How we verify

NCT03109548

Pre-treatment Factors for the Development of Chronic Pain in Low Back Pain Patients

Completed Last updated 10 May 2019
What this trial tests

trial testing Standard care initiated by the general practitioner in Low Back Pain in 58 participants. Completed in 6 November 2018.

Timeline
3 April 2017
Primary endpoint
6 November 2018
6 November 2018

Quick facts

Lead sponsorAalborg University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment58
Start date3 April 2017
Primary completion6 November 2018
Estimated completion6 November 2018
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Adults 18 to 80, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the project is to associate pre-treatment pain sensitivity level, levels of pain catastrophizing and levels of The Subgroups for Targeted Treatment (STarT) Back Screening Tool in patients with acute low back pain and patients' progression after 12 weeks of treatment by general practitioners.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing